Evidence map›Paper›PMID 40411652›Full record

ReviewStem cell reviews and reports2025

From Cells to Exosomes: a Review of Non-Surgical Biotherapeutic-Based Strategies for Liver Regeneration in the Face of End-Stage Diseases.

Fatemeh Askari Yazdian, Matin Mojaveri Samak, Amirhossein Larijani, Mohammad Taghi Ashoobi, Mohadese Kharaqani, Mohammad Amin Ghezel, Zahra Barabadi, Elham Vojoudi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Stem cell reviews and reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fatemeh Askari YazdianStudent Research Committee, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Matin Mojaveri SamakDepartment of Internal Medicine, School of Medicine, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.
Amirhossein LarijaniStudent Research Committee, School of Medicine, Guilan University of Medical Science, Rasht, Iran.
Mohammad Taghi AshoobiDepartment of General Surgery, School of Medicine Road Trauma Research Centre, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.
Mohadese KharaqaniBabol University of Medical Sciences, Babol, Iran.
Mohammad Amin GhezelStudent Research Committee, Babol University of Medical Sciences, Babol, Iran.
Zahra BarabadiDepartment of Tissue Engineering, School of Advanced Medical Sciences and Technologies, Hamadan University of Medical Sciences, Hamadan, Iran. z.barabadi@umsha.ac.ir.ORCID 0000-0002-3932-3734
Elham VojoudiRegenerative Medicine, Organ Procurement and Transplantation Multi-Disciplinary Centre, School of Medicine, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran. elhamvojoudi@gums.ac.ir.ORCID 0000-0002-6063-2873

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver diseases, such as hepatitis, cirrhosis, and liver cancer, pose significant public health challenges, ranking as the twelfth leading cause of death globally. Given the liver's critical functions in metabolism, detoxification, and biosynthesis, its impairment can lead to severe consequences, often resulting in end-stage liver failure. Although liver transplantation is regarded as the definitive intervention for advanced liver disease, factors such as a shortage of donors and potential surgical complications necessitate the investigation of non-surgical regenerative medicine alternatives. This manuscript provides a comprehensive review of innovative non-surgical therapies aimed at liver regeneration, with an emphasis on both cell-based and cell-free approaches. It examines the contributions of various stem cell populations, including mesenchymal stem cells, hematopoietic stem cells, and induced pluripotent stem cells, in facilitating liver repair through mechanisms of differentiation and paracrine signaling. Furthermore, it explores the therapeutic potential of exosomes and conditioned media derived from stem cells as biotherapeutic agents in the context of regenerative medicine. By elucidating the mechanisms that underpin liver regeneration, this study aspires to inform the development of effective therapeutic strategies to address liver diseases and slow their progression. By elucidating the underlying mechanisms of liver regeneration, this study aims to contribute to the development of effective therapeutic strategies to address liver diseases and slow their progression.

Indexed as

End Stage Liver DiseaseExosomesLiver RegenerationAnimalsClinical Trials as TopicDisease ProgressionHumansRegenerative MedicineStem CellsTerminally IllHepatocyteLiver diseasesRegenerative medicineStem cells

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.